Andrew L. Finn,Pharm.D
2013
In 2013, Andrew L. Finn,Pharm.D earned a total compensation of $1.1M as Executive VP of Product Development at BioDelivery Sciences International, a 130% increase compared to previous year.
Compensation breakdown
| Bonus | $124,680 |
|---|---|
| Salary | $313,514 |
| Stock Awards | $672,961 |
| Other | $28,185 |
| Total | $1,139,340 |
FinnPharmD received $673K in stock awards, accounting for 59% of the total pay in 2013.
FinnPharmD also received $124.7K in bonus, $313.5K in salary and $28.2K in other compensation.
Rankings
In 2013, Andrew L. Finn,Pharm.D's compensation ranked 6,044th out of 12,286 executives tracked by ExecPay. In other words, FinnPharmD earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,044 out of 12,286 | 51st |
Division Manufacturing | 2,102 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 619 out of 1,462 | 58th |
Industry group Drugs | 445 out of 1,156 | 62nd |
Industry Pharmaceutical Preparations | 357 out of 890 | 60th |
Source: SEC filing on June 5, 2015.
FinnPharmD's colleagues
We found five more compensation records of executives who worked with Andrew L. Finn,Pharm.D at BioDelivery Sciences International in 2013.
2013
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2013
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2013
Andrew Finn
BioDelivery Sciences International
Executive VP of Product Development
2013
Ernest De Paolantonio
BioDelivery Sciences International
Chief Financial Officer
2013
Ernest De PaolantonioCPA
BioDelivery Sciences International